Introduction
Hyponatraemia (serum sodium <135 mmol/L) is common. Presentation can cover a broad spectrum of symptoms and signs. Severe hyponatraemia can be life threatening requiring emergency assessment and treatment. This guidance covers emergency management of severe symptomatic hyponatraemia.
Recognition of the patient presenting with severe and moderately severe, symptomatic hyponatraemia
Biochemical assessment
The degree of biochemical hyponatraemia is classified in three groups: Management decisions should be made on the basis of presenting clinical symptoms and signs rather than the degree of hyponatraemia (1, 2). The decision to treat with hypertonic fluid and the supervision of treatment with hypertonic fluid should the responsibility of a senior clinician with appropriate training and experience. The aim is to achieve a 5 mmol/L rise in serum Na + within the first hour, reducing immediate danger from cerebral oedema while minimising the risk of over-rapid correction and osmotic demyelination.
Emergency Guidance
If the clinical status of the patient does not improve after a 5 mmol/L rise in serum Na + in the first hour, we recommend taking additional steps as outlined in Fig. 2 .
Managing over-correction of serum Na is exceeded, hypertonic fluid should be stopped. We recommend consulting a clinician with experience in managing over-correction who may wish to consider introducing hypotonic fluid, with or without concurrent anti-diuresis (3).
Differential diagnosis of hyponatraemia following emergency treatment
Measurement of urine osmolality and urine Na + concentration are central to defining the aetiology of hyponatraemia. An algorithmic approach to establishing the cause of hyponatraemia, in-line with other recent guidance, is outlined in Fig. 3 (1, 4) .
Disclaimer
The document should be considered as a guideline only; it is not intended to determine an absolute standard of medical care.
The doctors concerned must make the management plan for an individual patient.
